ACN
52
3
GE
67
2
ROP
62
3
TXT
55
3
MRK
25
-2
JPM
69
2
PM
62
-2
WFC
79
4
ES
34
3
SE
61
-4
MAT
46
12
ISRG
74
-2
DNB
82
4
MCHP
41
4
KMB
39
2
KHC
24
13
WEC
53
-2
KEY
46
3
EQIX
64
2
GS
75
2
ACN
52
3
GE
67
2
ROP
62
3
TXT
55
3
MRK
25
-2
JPM
69
2
PM
62
-2
WFC
79
4
ES
34
3
SE
61
-4
MAT
46
12
ISRG
74
-2
DNB
82
4
MCHP
41
4
KMB
39
2
KHC
24
13
WEC
53
-2
KEY
46
3
EQIX
64
2
GS
75
2
Financhill
Back

Integra Lifesciences Holdings Vs. Perspective Therapeutics Industry Stock Comparison

Sell
37

IART
Integra Lifesciences Holdings

Last Price:
23.55
Seasonality Move:
15.38%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
37
Integra Lifesciences Holdings (IART) is a Sell

Is Integra Lifesciences Holdings a Buy, Sell or Hold?

  • The current Integra Lifesciences Holdings [IART] share price is $23.58. The Score for IART is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • IART is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IART Stock Price Chart

What is Integra Lifesciences Holdings's stock price today?

  • The Integra Lifesciences Holdings share price today is $23.58
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IART is experiencing slight buying pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

IART Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.89 Buy
Relative Strength Index (14 RSI): 59.06 Buy
Chaikin Money Flow: 166404 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.54 - 24.66) Buy
Bollinger Bands (100): (17.69 - 26.65) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

IART Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.04 Buy
20-day SMA: 22.85 Buy
50-day SMA: 20.03 Buy
200-day SMA: 27.47 Sell
8-day EMA: 23.24 Buy
20-day EMA: 22.63 Buy
50-day EMA: 21.59 Buy
200-day EMA: 26.86 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

Integra Lifesciences Holdings Earnings Growth & IART Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.66 per share, and an increase next year of $0.06 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.78 per share, and a decrease next year of $0.49 per share.

Integra Lifesciences Holdings Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):